X-ray attenuation via iodine atoms in target tissue (None)

The phrase "X-ray attenuation via iodine atoms in target tissue" refers to the principle by which tissues containing significant concentrations of iodine absorb more X-rays than surrounding soft tissues during diagnostic imaging procedures such as CT scans and angiography. Iodine's high atomic number makes it highly effective at absorbing X-rays through photoelectric interactions—especially at energies near its K-edge (~33 keV), which matches well with typical diagnostic X-ray energies. When an iodinated compound is introduced into blood vessels or other body compartments as a contrast agent, regions where these compounds accumulate appear more opaque ("brighter") on resulting images due to increased attenuation relative to non-enhanced tissues. This differential absorption enables clinicians to visualize vascular structures and soft tissue abnormalities that would otherwise be indistinct on standard radiographs or CT scans[1][2][3][4]. This concept underpins much of modern medical imaging but does not represent an individual molecular drug target, receptor family member, enzyme class, etc., so should not be cataloged alongside true biomolecular targets without clarification.

Other names

Iodine-based contrast agentIodinated contrast mediaRadiographic iodine contrast

Increased photoelectric absorption and attenuation of X-rays due to high atomic number (Z=53) of iodine atoms present in tissue after administration; this creates greater image contrast between tissues containing iodine and those that do not[1][2][3][4].